Investing.com -- BofA Securities cut Alcon to “underperform” from “buy” rating, and lowered its price objective to CHF60 from CHF80, warning that weakened earnings prospects, slower surgical-equipment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results